In a recent study, the effect of IL-6 expression on TFG-ß related signaling pathways (STAT3, Smad3) in human lung fibroblasts derived from IPF patients could be antagonized by tocilizumab [32]. The gene discussed is SMAD3; the disease is idiopathic pulmonary fibrosis.